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Etiology and diagnostic work-up in young stroke
patients
Abstract
Ischemic stroke is not common in population of the young adults but when
they occur, clinical features and evaluation strategies are rather different from
adult patients in the usual stroke age group (50 to 85 years). Large epidemio-
logical studies based on hospital-based registries have demonstrated a broad
spectrum of aetiologies and risk factors. There is general agreement that young
adults have better chances of surviving a stroke than older individuals. How-
ever, the majority of survivors have emotional, social, or physical consequences
that impair their quality of life. Therefore, it is of great importance to recogni-
ze young adults who are at increased risk for stroke and to reduce their risk
factors as much as it is possible.
INTRODUCTION
Strokes are not especially common in the young but when they occur,clinical features and evaluation strategies are rather different from
adult patients in the usual stroke age group (50 to 85 years).
Cerebral infarction in young adults is responsible for significant
socioeconomic loss worldwide. Many studies based on hospital-based
registries have demonstrated a broad spectrum of aetiologies and risk
factors. In addition, unique aetiologies have also been identified such as
Moya-Moya syndrome, vascular dissections, haematological causes,
vasculitis and drugs in varying proportions.
Studies on young adults with cerebral infarctions in developed and
developing countries have observed large variations in the heterogeneity
of stroke subtypes and classification. Interestingly, strokes of undeter-
mined etiology varied widely from 5–44%while combined categories of
large vessel atherosclerosis and small vessel occlusion showed similar
large variation from 3%–42.5%. The cardioembolic category varied
from between 12.6% to 54% among studies while the proportions in the
undetermined or unknown category ranged from 15% to 42.5%. Many
conventional and recognised risk factors in young stroke patients have
also been described. Overall, the results showed these variations due to
many reasons including geographical location, referral bias, study metho-
dologies, classification schemes and the intensity of investigations.
There is general agreement that young adults have a better chances
of surviving a stroke than older individuals. However, the majority of
survivors have emotional, social, or physical disability that impair their
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Overview
providing child care or generating income for their fa-
milies. Therefore, the ability to predict prognosis would
be of paramount importance in this patient population
(1–9).
Etiologic variations associated with
age
The range of potential etiologies for stroke in young
adults is broader than that for older adults. (Table 1)
Like in older adults, stroke in younger adults is typi-
cally categorized as primarily ischemic or hemorrhagic.
Ischemic etiologies include cardioembolic, atherosclerotic
disease, and nonatherosclerotic cerebral vasculopathies.
Hemorrhagic strokes include subarachnoid and intra-
parenchymal types. Of particular note in young adults
are stroke causes such as hematologic disorders, sub-
stance abuse, trauma, dissections, oral contraceptive use,
pregnancy and postpartum states, and migraine.
Cardioembolic Stroke
Cardiac – origin embolism is a very important cause
of stroke in young adults. The cardiac disorders respon-
sible are, however, somewhat different than those found
in childhood and older adult series. Congenital cardiac
disease and atrial fibrillation, congestive heart failure and
coronary artery disease-related myocardial dysfunctio-
nare not frequent cardiac sources in patients aged 15 to
45. In some recent series, atrial septal defects and patent
foramen ovale with or without atrial septal aneurysms
are mentioned as the predominant cardiac source of
embolism (10).
The potential link between PFO and young stroke
remains a controversial subject. Somewhere in the area
of twenty-five percent of the population have a PFO,
which in itself is not associated with an increased inci-
dence of first ever stroke in large population studies,
although a nonsignificant trend toward an association
has been observed, particularly among individuals under
the age of 60 with an atrial septal aneurysm (ASA). PFO
is, however, a more common finding among young pa-
tients who present with cryptogenic stroke (11–13).
Thrombophilia in the Setting of PFO and
Stroke
While thrombophilia on its own is probably not as-
sociated with ischaemic stroke, there is some evidence to
suggest that the prothrombin gene mutation, in particu-
lar, might confer a greater risk of ischaemic stroke in the
setting of a PFO. As nongenetic laboratory assays in the
assessment of coagulopathies may be unreliable in the
acute phase of stroke, the most reliable studies use genetic
testing to identify patients with inherited thrombophilias
(14, 15).
Migraine and Stroke
Theweight of evidence from case-control studies sug-
gests that migraine, particularly migraine with aura, is
associated with an increased risk of ischaemic stroke in
young women under 45 years of age. The pathophysio-
logical mechanism underlying this remains unclear. For
one, it is difficult to tease out the relative contribution of
cases in whichmigraine precedes ischaemia (i.e., in which
stroke occurs secondary to cerebral hypoperfusion dur-
ing the aura phase), comprising a migrainous infarct,
from cases in which migraine with aura is experienced
secondary to ischaemia. True migrainous infarcts are
probably rare and tend to affect the posterior circulation.
It is also possible that young patients with a history of
migraine have an increased incidence of stroke due to a
shared underlying etiology which predisposes to both.
Migraine as a risk factor for future ischaemic stroke
seems to apply mostly to young women, and the relative
risk may be as high as 3-fold in those who experience
migraine with aura. Several associations which might
predispose to stroke in migraineurs have been identified
in a small number of case-control studies, including
carotid artery dissection and the presence of a patent
foramen ovale; however, this does not explain the observ-
ed sex difference in the frequency of ischaemic stroke
among migraineurs. What is known is that there is an
additive risk of stroke in women who experience migrai-
ne with aura that smoke, with a greater than 3-fold
increase in risk, as well as in those who use the oral
contraceptive pill, in whom the risk is quadrupled. An
OR of 34 to 35 has been reported for young women who
smoke, use the oral contraceptive pill, and experience
migraine with aura (16, 17).
Stroke and Puerperium
Stroke complicates an estimated 34 in 100000 delive-
ries, although reported incidence rates vary from 4 to 210
in 100000 deliveries, contributing to at least 12% of ma-
ternal deaths. Some reports suggest that ischaemic and
haemorrhagic stroke occur in roughly equal proportions,
although ischaemic stroke was more common in one
study. Thismay be due to differences in patient subgroup
selection since some studies exclude stroke secondary to
cerebral venous thrombosis, which contributes to a signi-
ficant proportion of ischaemic strokes in the puerperium.
Nonetheless, arterial occlusion remains most common.
Most strokes occur peri- or postpartum with a relative
risk of 8.7 for ischaemia in the first six weeks postpartum,
during which cerebral vein thrombosis is also more com-
mon, and a relative risk of 5.6 for intracerebral haemorrh-
age during pregnancy. Looking at intracerebral and sub-
arachnoid haemorrhage combined, a 2.5-fold increased
risk of haemorrhagic stroke has been reported in preg-
nancy, and a 23.8-fold increased risk postpartum. Half of
cases of aneurysmal rupture in women under the age of
40 occur in pregnancy. Causes of stroke in pregnancy
include haemorrhagic and ischaemic stroke in the setting
of pre-eclampsia and eclampsia (25–45% of patients with
pregnancy-related stroke), arterial dissection, peripartum
cardiomyopathy, paradoxical embolism, amniotic fluid
embolism, postpartum cerebral angiopathy, and cerebral
vein thrombosis. Cerebral haemorrhage is themost com-
mon cause of death in patients with eclampsia but asso-
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ciations between pre-eclampsia and eclampsia and ischae-
mic stroke are also observed. Subarachnoid haemorrhage
is the third leading cause of nonobstetric-related maternal
death, often secondary to aneurysmal rupture. Whether
or not the presence of a patent foramen ovale alone is
associated with an increased stroke risk in pregnancy has
not been properly examined, nor has the incidence of
pregnancy-related stroke in association with peripartum
cardiomyopathy. Post-partum angiopathy, a reversible ce-
rebral vasoconstriction syndrome usually occurring in
the first week postpartum, may be more common than
initially thought, although the exact incidence is un-
known. It may or may not be associated with pre-eclam-
psia or eclampsia and cases have also been seen in as-
sociation with vasospastic drugs, such as ergonovine and
bromocriptine during pregnancy (8–11).
Extracranial Arterial Dissection
Cervical artery dissection (CAD) accounts for up to
one fifth of ischaemic strokes in young and middle-aged
patients. In a majority of cases, the specific etiology re-
mains unknown. Trauma, infection, migraine, fibromus-
cular dysplasia, and a range other causes have been linked
withCADbut evidence to support strong links is limited.
With regard to CAD epidemiological observations
suggest that some as-yet unrecognized predisposing fac-
tors could be heritable. A recent meta-analysis has observ-
ed a probable link with Ehlers-Danlos but no other con-
sistent associations, although there is little doubt that ge-
netic factors play a role given the high proportion of con-
nective tissue defects noted on specimens and the observ-
ed clustering of CAD in families. Environmental trig-
gers, such as infection, are likely also important (19–22).
Monogenic diseases
There are more than 50 monogenic diseases that can
cause stroke, but they account for a very low percentage
of strokes. These disorders are very rare, apart from dre-
panocytosis, which is an important cause of stroke in
children and young adults of African ethnic origin. In
young patients of African origin with stroke, sickle-cell
disease should always be looked for by use of haemo-
globin electrophoresis (haemoglobin S) or genetic testing
(Val-Glu ubstitution in the b globin chain). Follow-up of
intracranial stenosis can be done non-invasively with
transcranial doppler. Subcortical vascular dementia, de-
pression and other psychiatric disorders, migraine with
aura, and recurrent strokes are the main clinical features
of CADASIL. The diagnosis is suspected if there is a
family history (autosomal dominant) and if MRI shows
the characteristic confl uent subcortical white matter
changes extending to the temporal lobes. The diagnosis
is confi rmed by skin biopsy and genetic testing (Notch 3
mutations). The estimated prevalence of CADASIL in
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TABLE 1
Differential diagnosis of ischemic stroke in young adults.
Cardiac disease (including congenital, rheumatic valve disease, mitral valve prolapse, patent foramen ovale, endocarditis, atrial
myxoma, arrhythmias, cardiac surgery)
Large vessel disease
Premature atherosclerosis
Dissection (spontaneous or traumatic)
Inherited metabolic diseases (homocystinuria, Fabry’s, pseudoxanthoma elasticum, MELAS syndrome)
Fibromuscular dysplasia
Infection (bacterial, fungal, tuberculosis, syphilis, Lyme)
Vasculitis (collagen vascular diseases— systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s syndrome, polyarteritis nodosa;




Toxic (illicit drugs— cocaine, heroin, phencyclidine; therapeutic drugs— L-asparaginase, cytosine arabinoside)
Small vessel disease





Hypercoagulable states (antiphospholipid antibody syndromes, deficiency of antithrombin III or protein S or C, resistance to activated





Venous occlusion (dehydration, parameningeal infection, meningitis, neoplasm, polycythemia, leukemia, inflammatory bowel disease)
Migraine
young patients with stroke is very low (0 E 5% of lacunar
strokes; 2% in patients younger than 65 years with white
matter changes). Hypertension and smoking are asso-
ciated with an increased probability of stroke in patients
with CADASIL, suggesting that vascular risk factors might
modulate the clinical expression of this disorder.
The availability of an effective enzyme (a-galactosi-
dase) substitution therapy has led to a renewed interest in
Fabry's disease as a cause of stroke in young adults.
Fabry's disease is a systemic disorder affecting mainly
the kidney, skin (angiokeratoma), and eye (corneal opa-
cities). It causes a painful neuropathy. The diagnosis in
symptomatic men can be confirmed by a deficit in serum
a-galactosidase, but usually needs genetic testing, parti-
cularly in women, who can have normal concentrations
of a-galactosidase.
Vertebrobasilar dolicoectasia and the coexistence of
large-vessel and small-vessel disease are suggestive of
Fabry’s disease. Fabry’s disease is more frequent in young
patients with cryptogenic ischaemic stroke. In two large
multicentre studies of young patientswith stroke,a-galacto
sidase pathogenic mutations were recorded in 2 E4%3 of
493 and 1% of 1000 patients with strokes, more often in
those with ischaemic stroke (both cryptogenic and
non-cryptogenic). In one of these studies,3 a-galactosidase
pathogenicmutationsweremore frequent in patientswith
evidence of small-vessel disease (lacunes or leukoaraiosis;
4E5%), more so if they were not hypertensive (7%), and in
normotensive patients with posterior circulation strokes (12
E5%).Of importance is the fact that stroke frequently arises
before diagnosis of Fabry’s disease and in the absence of
other clinical findings (23–25).
Cryptogenic stroke
In about 30% of patients, the cause of stroke cannot be
identified despite the detailed and comprehensive aetio-
logical work up. Some of these patients might have clas-
sic vascular risk factors, but they do not show evidence of
large atherosclerotic or smallvessel arterial disease. Mi-
nor atherosclerotic lesions might be missed by current
diagnostic and imaging techniques. A frequent mistake
is the diagnosis of cryptogenic stroke in patients with
incomplete or delayed aetiological investigation. This
misdiagnosis is of particular importance in dissection,
which can resolve quickly, and in intracardiac thrombus,
which can either resolve or fragment and embolise. Re-
sults of some biological diagnostic tests (eg, antiphos-
pholipid antibodies for antiphospholipid syndrome or
platelet count for thrombocythaemia) can fluctuate, and
therefore repeated assessment is needed. Repeated or
extended Holter monitoring might be necessary if pa-
roxysmal arrhythmias are suspected. Repeated angio-
graphy might also be necessary to distinguish between
reversible cerebral vasoconstriction syndrome, in which
the various segmental arterial narrowings are reversible,
and vasculitis, atherosclerosis, or other vasculopathies of
intracranial arteries, in which the narrowings persist or
even progress.
Diagnostic procedures
The initial work-up should be as expeditious as pos-
sible to allow consideration of acute therapies, such as
tissue plasminogen activator (t-PA) (26). Brain com-
puted tomography (CT) is usually the initial imaging
study of choice as it is readily available and is highly
sensitive for acute hemorrhage. Blood work should in-
clude a complete blood count with differential and plate-
let count, prothrombin time (international normalized
ratio), activated partial thromboplastin time, glucose,
chemistries, electrolytes, serology for syphilis, and an
erythrocyte sedimentation rate.
A more detailed coagulation profile (anticardiolipin
antibodies, lupus anticoagulants, protein S, protein C,
activated protein C resistance, antithrombin III) is re-
quested in patients without a firmly identified cause of
stroke or if the patient or family members have a history
of thromboses. It is advantageous to send such a profile
prior to initiating anticoagulation, as heparin can alter
interpretation of some of those assays. Therefore, consider
ordering these assays at the beginning of the work-up.
Most patients should have high-quality brain mag-
netic resonance imaging (MRI) and often MRA (27).
Where available, MRI with diffusion-weighted imaging
(DWI) and perfusion imaging (PI) is becoming stan-
dard. DWI-PI has the potential to distinguish irrever-
sibly injured tissue from that which may be salvageable
(28).
Additional studies in initial screening include preg-
nancy testing, a chest roentgenogram, and an electro-
cardiogram. An echocardiogram (consider transesopha-
geal), and extracranial (carotid-vertebral) Doppler ultra-
sound are routinely obtained, although often after initial
antiplatelet or anticoagulation therapy is started.
Keep in mind the limitations of studies performed.
CT will miss a minority of acute bleeds. MRI with DWI,
quite sensitive for acute stroke, has an occasional false
negative result (17 out of 782 patients in a recent study).
Also, MRA’s resolution is not yet on par with conventio-
nal angiography.
Consider conventional angiography of cerebral and
neck vessels for patients in whom dissection is suspected
or in whom no other cause is found. Transcranial Dop-
pler ultrasound can be helpful.
Toxicologic studies are often productive, even when
drug use is not acknowledged.
Other blood tests may include homocysteine, fibri-
nogen, antinuclear antibody, lipid panel, lipoprotein (a),
serum protein electrophoresis, hemoglobin electropho-
resis, and sickle-cell assay. Cerebrospinal fluid analysis is
indicated for cases suspicious for infectious, vasculitic, or
occult hemorrhage origins. Telemetry monitoring for ar-
rhythmias is occasionally revealing.
Prothrombin mutation G20210A testing is of uncer-
tain utility in cerebrovascular disease, but may be appro-
priate for patients with a personal history of thrombo-
embolic disease or family history of thrombophilia (29).
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A patient with one ormore risk factors, such asmigra-
ine or diabetes, should be thoroughly investigated for
other possibilities. The cause of stroke in young patients
may remain undetermined in 20% to 30% of cases, even
after a detailed work-up.
Prognosis. The outcome of stroke in young adults is
better than that for older adults. The absence of gene-
ralized vascular disease and presence of good collateral
circulation often minimizes the eventual brain damage,
making the ultimate infarct smaller than in adults. Also,
the developing brain shows more plasticity. Undamaged
areas can frequently assume the functions of damaged
regions. As a result, focal disorders of cognition and
aphasia often improve, leaving no major speech deficit,
although general intellectual function may be less than
expected before the stroke. Although the prognosis is
better than in the geriatric age group, strokes in the
young are far from benign.
In a recent study of 330 patients with first stroke or
transient ischemic attack, followed for an average of 96
months, 8% died, 3% had another stroke, and 3% had a
myocardial infarction. Approximately 16% were depen-
dent, but 56% had returned to work. Unfortunately, only
aminority of thosewho smoked at the time of their stroke
subsequently stopped using tobacco (30). The overall
annual recurrence rate is less than 1%. Prognosis is often
closely associated with the underlying cause. A relatively
good outcome may be found after many cases of arterial
dissection. Risk of stroke recurrence is low (2% over 5
years) in women whose first stroke occurred in preg-
nancy (31, 32).
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